Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 707

1.

[Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis].

Hida T, Yamasaki T, Banno H, Fuchigami Y, Hattahara K, Fujiwara M, Suzuki R, Kita Y, Yoshino T, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.

Hinyokika Kiyo. 2019 Oct;65(10):413-419. doi: 10.14989/ActaUrolJap_65_10_413. Japanese.

PMID:
31697887
2.

'Trifecta' outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study.

Furukawa J, Kanayama H, Azuma H, Inoue K, Kobayashi Y, Kashiwagi A, Segawa T, Takahashi Y, Horie S, Ogawa O, Takenaka A, Shiroki R, Tanabe K, Fujisawa M.

Int J Clin Oncol. 2019 Nov 1. doi: 10.1007/s10147-019-01565-0. [Epub ahead of print]

PMID:
31677020
3.

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.

Kita Y, Hamada A, Saito R, Teramoto Y, Tanaka R, Takano K, Nakayama K, Murakami K, Matsumoto K, Akamatsu S, Yamasaki T, Inoue T, Tabata Y, Okuno Y, Ogawa O, Kobayashi T.

Br J Cancer. 2019 Nov 1. doi: 10.1038/s41416-019-0609-0. [Epub ahead of print]

PMID:
31673101
4.

eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA.

Mizuno K, Akamatsu S, Sumiyoshi T, Wong JH, Fujita M, Maejima K, Nakano K, Ono A, Aikata H, Ueno M, Hayami S, Yamaue H, Chayama K, Inoue T, Ogawa O, Nakagawa H, Fujimoto A.

Sci Rep. 2019 Oct 22;9(1):15017. doi: 10.1038/s41598-019-51459-4.

5.

Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.

Negoro H, Goto T, Akamatsu S, Terada N, Kobayashi T, Matsui Y, Yamamoto T, Omura T, Yonezawa A, Matsubara K, Ogawa O.

Neurourol Urodyn. 2019 Oct 2. doi: 10.1002/nau.24175. [Epub ahead of print]

PMID:
31578771
6.

12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.

Takata R, Takahashi A, Fujita M, Momozawa Y, Saunders EJ, Yamada H, Maejima K, Nakano K, Nishida Y, Hishida A, Matsuo K, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Sasaki M, Shimizu A, Tanno K, Minegishi N, Suzuki K, Matsuda K, Kubo M, Inazawa J, Egawa S, Haiman CA, Ogawa O, Obara W, Kamatani Y, Akamatsu S, Nakagawa H.

Nat Commun. 2019 Sep 27;10(1):4422. doi: 10.1038/s41467-019-12267-6.

7.

A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study.

Inoue T, Miura M, Yanishi M, Furukawa J, Sato F, Nitta M, Yoshimura K, Hagiuda J, Shinoda K, Kobayashi T, Miyajima A, Nakagawa K, Oya M, Ogawa O, Mimata H, Kanayama HO, Fujisawa M, Terachi T, Matsuda T, Habuchi T; LESS and RPS Research Group in Japanese Society of Endourology.

Surg Endosc. 2019 Sep 23. doi: 10.1007/s00464-019-07119-9. [Epub ahead of print]

PMID:
31549237
8.

Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations.

Goto T, Inoue T, Kobayashi T, Yamasaki T, Ishitoya S, Segawa T, Ito N, Shichiri Y, Okumura K, Okuno H, Kawakita M, Kanaoka T, Terada N, Mukai S, Sugi M, Kinoshita H, Kamoto T, Matsuda T, Ogawa O.

Int J Clin Oncol. 2019 Aug 30. doi: 10.1007/s10147-019-01533-8. [Epub ahead of print]

PMID:
31471786
9.

Data processing on a comparative evaluation of the extraction and analysis procedures for urinary phospholipid and lysophospholipid using MALDI-TOF/MS.

Li X, Nakayama K, Goto T, Akamatsu S, Shimizu K, Ogawa O, Inoue T.

Data Brief. 2019 Jul 15;25:104275. doi: 10.1016/j.dib.2019.104275. eCollection 2019 Aug.

10.

Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology.

Saito R, Kobayashi T, Kashima S, Matsumoto K, Ogawa O.

Int J Clin Oncol. 2019 Aug 12. doi: 10.1007/s10147-019-01520-z. [Epub ahead of print] Review.

PMID:
31407168
11.

Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice.

Murakami K, Hamada A, Teramoto Y, Matsumoto K, Kita Y, Saito R, Yamasaki T, Matsui Y, Inoue T, Ogawa O, Kobayashi T.

Clin Genitourin Cancer. 2019 Oct;17(5):e1003-e1010. doi: 10.1016/j.clgc.2019.05.028. Epub 2019 May 30.

PMID:
31402280
12.

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.

Kawahara T, Kojima T, Kandori S, Kurobe M, Yoshino T, Kimura T, Nagumo Y, Ishituka R, Mitsuzuka K, Narita S, Kobayashi T, Matsui Y, Ogawa O, Sugimoto M, Miyazaki J, Nishiyama H.

PLoS One. 2019 Aug 1;14(8):e0220173. doi: 10.1371/journal.pone.0220173. eCollection 2019.

13.

Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer.

Fujiwara M, Akamatsu S, Sumiyoshi T, Segawa T, Mizuno K, Yoshino T, Goto T, Sawada A, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.

Clin Genitourin Cancer. 2019 Oct;17(5):e923-e929. doi: 10.1016/j.clgc.2019.04.017. Epub 2019 Jun 12.

PMID:
31307917
14.

Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma.

Goto M, Chamoto K, Higuchi K, Yamashita S, Noda K, Iino T, Miura M, Yamasaki T, Ogawa O, Sonobe M, Date H, Hamanishi J, Mandai M, Tanaka Y, Chikuma S, Hatae R, Muto M, Minamiguchi S, Minato N, Honjo T.

Sci Rep. 2019 Jul 12;9(1):10144. doi: 10.1038/s41598-019-46548-3.

15.

Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS.

Li X, Nakayama K, Goto T, Akamatsu S, Shimizu K, Ogawa O, Inoue T.

Chem Phys Lipids. 2019 Sep;223:104787. doi: 10.1016/j.chemphyslip.2019.104787. Epub 2019 Jun 27.

PMID:
31255592
16.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S; JCOG UOSG.

J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.

PMID:
31251717
17.

[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].

Hattahara K, Yamasaki T, Sawada A, Tanigaki K, Endo S, Teramoto Y, Banno H, Fuchigami Y, Suzuki R, Fujiwara M, Hida T, Yoshino T, Kita Y, Goto T, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.

Hinyokika Kiyo. 2019 May;65(5):157-161. doi: 10.14989/ActaUrolJap_65_5_157. Japanese.

PMID:
31247693
18.

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.

Akamatsu S, Kubota M, Uozumi R, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, Hoshi S, Ishida M, Mizuno K, Ogura K, Goto T, Terada N, Kobayashi T, Yamasaki T, Inoue T, Tsuchiya N, Ohyama C, Arai Y, Habuchi T, Morita S, Ogawa O.

Eur Urol Oncol. 2019 May;2(3):320-328. doi: 10.1016/j.euo.2018.10.011. Epub 2018 Nov 23.

PMID:
31200847
19.

Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.

Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.

Int J Clin Oncol. 2019 Oct;24(10):1247-1255. doi: 10.1007/s10147-019-01478-y. Epub 2019 May 31.

20.

Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome.

Ueda M, Sengiku A, Kono J, Negoro H, Saito R, Yoshimura N, Ogawa O, Ueda T.

Int J Urol. 2019 Jun;26 Suppl 1:53-56. doi: 10.1111/iju.13975.

PMID:
31144759
21.

No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug-Drug Interaction Study.

Otani N, Wakuda H, Imai H, Kuranari M, Ishii Y, Ito Y, Okubo A, Ogawa O, Takeda K, Ohyama T, Hasunuma T, Uemura N.

Clin Transl Sci. 2019 Sep;12(5):513-518. doi: 10.1111/cts.12646. Epub 2019 Jun 4.

22.

Reply by Authors.

Fukunaga A, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Matsuda F, Yoshimura K, Ogawa O, Negoro H; Nagahama Study Group.

J Urol. 2019 Aug;202(2):360-361. doi: 10.1097/01.JU.0000559826.09631.1d. Epub 2019 Jul 8. No abstract available.

PMID:
31095468
23.

Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.

Uegaki M, Kita Y, Shirakawa R, Teramoto Y, Kamiyama Y, Saito R, Yoshikawa T, Sakamoto H, Goto T, Akamatsu S, Yamasaki T, Inoue T, Suzuki A, Horiuchi H, Ogawa O, Kobayashi T.

Carcinogenesis. 2019 May 6. pii: bgz082. doi: 10.1093/carcin/bgz082. [Epub ahead of print]

PMID:
31058283
24.

Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomes.

Tanaka N, Nishimura K, Okajima E, Ina K, Ogawa O, Nagata H, Akakura K, Fujimoto K, Gotoh M, Teramukai S, Hirao Y.

Int J Urol. 2019 Aug;26(8):797-803. doi: 10.1111/iju.14009. Epub 2019 May 5.

PMID:
31055879
25.

Consecutive Prostate Cancer Specimens Revealed Increased Aldo⁻Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer.

Miyazaki Y, Teramoto Y, Shibuya S, Goto T, Okasho K, Mizuno K, Uegaki M, Yoshikawa T, Akamatsu S, Kobayashi T, Ogawa O, Inoue T.

J Clin Med. 2019 May 1;8(5). pii: E601. doi: 10.3390/jcm8050601.

26.

Hormone Therapy and Castration Resistance of Prostate Cancer.

Arai Y, Ogawa O.

Can J Urol. 2019 Apr;26(2):9686. No abstract available.

27.

Recurrent Aphthous Stomatitis Caused by Cytomegalovirus, Herpes Simplex Virus, and Candida Species in a Kidney Transplant Recipient: A Case Report.

Ito K, Okuno T, Sawada A, Sakai K, Kato Y, Muro K, Yanagita M, Teramoto Y, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.

Transplant Proc. 2019 Apr;51(3):993-997. doi: 10.1016/j.transproceed.2019.01.058. Epub 2019 Jan 26.

PMID:
30979493
28.

Estimating the Net Utility Gains Among Donors and Recipients of Adult Living Donor Kidney Transplant.

Hiragi S, Goto R, Tanaka Y, Matsuyama Y, Sawada A, SakaI K, Miyata H, Tamura H, Yanagita M, Kuroda T, Ogawa O, Kobayashi T.

Transplant Proc. 2019 Apr;51(3):676-683. doi: 10.1016/j.transproceed.2019.01.049. Epub 2019 Jan 26.

PMID:
30979450
29.

Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.

Ito K, Kanno T, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.

Int J Clin Oncol. 2019 Sep;24(9):1081-1088. doi: 10.1007/s10147-019-01446-6. Epub 2019 Apr 10.

PMID:
30972505
30.

RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.

Kato I, Furuya M, Baba M, Kameda Y, Yasuda M, Nishimoto K, Oyama M, Yamasaki T, Ogawa O, Niino H, Nakaigawa N, Yano Y, Sakamoto K, Urata Y, Mikami K, Yamasaki S, Tanaka R, Takagi T, Kondo T, Nagashima Y.

Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25.

PMID:
30908700
31.

Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study.

Fukunaga A, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Matsuda F, Yoshimura K, Ogawa O, Negoro H; Nagahama Study Group.

J Urol. 2019 Aug;202(2):354. doi: 10.1097/JU.0000000000000212. Epub 2019 Jul 8.

PMID:
30865558
32.

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.

Sumiyoshi T, Mizuno K, Yamasaki T, Miyazaki Y, Makino Y, Okasho K, Li X, Utsunomiya N, Goto T, Kobayashi T, Terada N, Inoue T, Kamba T, Fujimoto A, Ogawa O, Akamatsu S.

Sci Rep. 2019 Mar 11;9(1):4030. doi: 10.1038/s41598-019-40719-y.

33.

[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments].

Imai K, Inoue T, Saito R, Goto T, Sawada A, Akamatsu S, Negoro H, Kobayashi T, Terada N, Yamasaki T, Okubo K, Yoshimura K, Kanematsu A, Ogawa O.

Hinyokika Kiyo. 2019 Jan;65(1):13-17. doi: 10.14989/ActaUrolJap_65_1_13. Japanese.

PMID:
30831672
34.

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone.

Shiota M, Narita S, Akamatsu S, Fujimoto N, Sumiyoshi T, Fujiwara M, Uchiumi T, Habuchi T, Ogawa O, Eto M.

JAMA Netw Open. 2019 Feb 1;2(2):e190115. doi: 10.1001/jamanetworkopen.2019.0115.

35.

Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.

Sugiyama Y, Yatsuda J, Murakami Y, Ito N, Yamasaki T, Mikami Y, Ogawa O, Kamba T.

Jpn J Clin Oncol. 2019 May 1;49(5):465-472. doi: 10.1093/jjco/hyy200.

PMID:
30793163
36.

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients.

Terada N, Kamoto T, Tsukino H, Mukai S, Akamatsu S, Inoue T, Ogawa O, Narita S, Habuchi T, Yamashita S, Mitsuzuka K, Arai Y, Kandori S, Kojima T, Nishiyama H, Kawamura Y, Shimizu Y, Terachi T, Sugi M, Kinoshita H, Matsuda T, Yamada Y, Yamamoto S, Hirama H, Sugimoto M, Kakehi Y, Sakurai T, Tsuchiya N.

BMC Cancer. 2019 Feb 15;19(1):156. doi: 10.1186/s12885-019-5342-9.

37.

Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort.

Kanno T, Ito K, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.

Int J Urol. 2019 Apr;26(4):493-498. doi: 10.1111/iju.13917. Epub 2019 Feb 1.

PMID:
30710377
38.

Initial evaluation of PET/CT with 18 F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients.

Saga T, Nakamoto Y, Ishimori T, Inoue T, Shimizu Y, Kimura H, Akamatsu S, Goto T, Watanabe H, Kitaguchi K, Watanabe M, Ono M, Saji H, Ogawa O, Togashi K.

Cancer Sci. 2019 Feb;110(2):742-750. doi: 10.1111/cas.13911. Epub 2019 Jan 4.

39.

[Initial Clinical Experience of Nivolumab for Metastatic Renal Cell Carcinoma].

Fukunaga A, Yamasaki T, Okuno T, Imai K, Ikeuchi R, Hishiki K, Goto T, Sawada A, Negoro H, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.

Hinyokika Kiyo. 2018 Oct;64(10):383-389. doi: 10.14989/ActaUrolJap_64_10_383. Japanese.

40.

Sperm cryopreservation: Clinical and fertility outcomes in male oncological patients with germ cell tumors or hematological disorders.

Negoro H, Matsui Y, Nakayama T, Hatayama H, Ogawa O, Ichioka K.

Reprod Med Biol. 2018 Sep 30;17(4):500-503. doi: 10.1002/rmb2.12246. eCollection 2018 Oct.

41.

Laparoscopic excision of an acquired ureteral diverticulum: A case report.

Negoro H, Inoue T, Imai K, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamasaki T, Ogawa O.

Asian J Endosc Surg. 2019 Oct;12(4):478-481. doi: 10.1111/ases.12663. Epub 2018 Oct 24.

PMID:
30358128
42.

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges.

Kita Y, Goto T, Akamatsu S, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.

Cancers (Basel). 2018 Sep 21;10(10). pii: E345. doi: 10.3390/cancers10100345. Review.

43.

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866.

PMID:
30165444
44.

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching.

Onozawa M, Akaza H, Hinotsu S, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Tsukamoto T.

Cancer Med. 2018 Oct;7(10):4893-4902. doi: 10.1002/cam4.1735. Epub 2018 Aug 27.

45.

Gliding Basal Cell Migration of the Urothelium during Wound Healing.

Sano T, Kobayashi T, Ogawa O, Matsuda M.

Am J Pathol. 2018 Nov;188(11):2564-2573. doi: 10.1016/j.ajpath.2018.07.010. Epub 2018 Aug 16.

PMID:
30121259
46.

Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP.

Ito K, Takashima Y, Akamatsu S, Terada N, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Negoro H.

Neurourol Urodyn. 2018 Sep;37(7):2160-2166. doi: 10.1002/nau.23428. Epub 2018 Aug 10.

PMID:
30095172
47.

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.

Nakamura K, Ikeda I, Inokuchi H, Takayama K, Inoue T, Kamba T, Ogawa O, Hiraoka M, Mizowaki T.

J Radiat Res. 2018 Sep 1;59(5):656-663. doi: 10.1093/jrr/rry060.

48.

A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis.

Sakamoto H, Yamasaki T, Sumiyoshi T, Utsunomiya N, Takeda M, Kamba T, Nakamura E, Ogawa O.

J Clin Pathol. 2018 Oct;71(10):936-943. doi: 10.1136/jclinpath-2018-205211. Epub 2018 Jun 30.

PMID:
29960980
49.

Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects.

Ishii Y, Ito Y, Matsuki S, Sanpei K, Ogawa O, Takeda K, Schuck EL, Uemura N.

Clin Transl Sci. 2018 Sep;11(5):477-486. doi: 10.1111/cts.12557. Epub 2018 May 16.

50.

Characterization of Helicobacter pylori-Naïve Early Gastric Cancers.

Yamada A, Kaise M, Inoshita N, Toba T, Nomura K, Kuribayashi Y, Yamashita S, Furuhata T, Kikuchi D, Matsui A, Mitani T, Ogawa O, Iizuka T, Hoteya S.

Digestion. 2018;98(2):127-134. doi: 10.1159/000487795. Epub 2018 May 2.

PMID:
29719284

Supplemental Content

Support Center